N1A Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Navamedic ASA

Watchlist Manager

Watchlist

Price: 1.45 EUR 3.2% Market Closed

Market Cap: €25.3m

N	Navamedic ASA F:N1A	NO
A	Acea SpA XMUN:DCA	IT
I	Itron Inc XBER:IT6	US
T	Telo Genomics Corp F:3D0A	CA
C	Capgemini SE F:CGM	FR
S	Sonic Automotive Inc F:SA8A	US
	UIE PLC F:I55	MT
M	Merck & Co Inc XMUN:6MK	US
	Yalla Group Ltd F:80Q	AE
	Pierce Group AB (publ) F:959	SE
W	Warner Music Group Corp F:WA4	US

Profitability Summary

Navamedic ASA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

39%

Sustainable 3Y Average Gross Margin

39%

Declining Gross Margin

42% > 39%

Low Operating Margin

Low 3Y Average Operating Margin

Declining Operating Margin

8% > 1%

Negative Net Margin

-3%

Negative 3Y Average Net Margin

-1%

Declining Net Margin

4% > -3%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

7% > 2%

Negative ROE

-6%

Negative 3Y Average ROE

Positive 3Y Average ROIC

12%

Declining ROIC

7% > 1%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.